Injectable Drug Delivery Resources

1. Key Considerations For Emerging Companies When Selecting Packaging Components

   Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.

2. Nasal Vaccine Development, Manufacturing, And Device Selection 7/11/2023

   When developing a nasal delivery program, a partner with experience in development and manufacturing techniques who can see a program through small-scale clinical to commercial supply is crucial.

3. Elastomer Plungers With Barrier Film For COVID-19 Vaccines

   Minimize the risks of accelerated drug development processes and the potential use of new vaccine platform technologies with the use of an elastomer plunger laminated with FluroTec™ barrier film.

4. De-Risking The Transition From Vial To Drug-Device Combination Product 7/25/2025

   When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

5. High-Throughput Platform Propels Gene Editing Therapy Research 3/1/2024

   Explore the potential of polymeric nanoparticles (PNPs) as an alternative to viral vectors. PNPs offer design flexibility, enabling larger payloads, targeted release, and minimized side effects.

6. Essential Drug Delivery Outputs For Devices To Deliver Drugs, Biologics 5/16/2025

   All future submissions are expected to align with FDA's draft guidance that clarifies the agency's expectations for establishing, evaluating, and controlling Essential Drug Delivery Output (EDDO) requirements.

7. The Future Of CDMOs: Aseptic Filling Solutions For Growth And Innovation 9/15/2023

   The rapid rise of highly targeted cell and gene treatments requiring small batch production necessitates a new path forward for biologics manufacturing and directly impacts the CMO/CDMO landscape.

8. Fixtures And Surrogates For Combination Product Performance Testing 5/16/2025

   The combination product market is consistently expanding. Transitioning from traditional vial systems to needle-based combination products presents several challenges that require careful consideration.

9. Is It Ever Too Soon To Start Your Extractables And Leachables Assessment?

   Learn what you need to know about planning for your extractables and leachables testing programs to mitigate delays to your drug development timelines.

10. Small-Scale Aseptic Filling Technology Considerations 2/23/2023

    Small-scale aseptic filling presents a unique set of challenges. Learn what to look for when evaluating small-scale aseptic filling technology.